La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Angiotensin II in Liver Transplantation | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibrosis, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Urogenital Diseases, Vasoplegia, acute kidney injury, cardiovascular disorder, hypotensive disorder, kidney disorder, kidney failure, urinary system disorder, vascular disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-03-20 | NCT04901169 | |
| ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery) | Aneurysm, cardiovascular disorder, hypotensive disorder, vascular disorder | Recruiting | Phase 4 | 2025-12-22 | NCT06487585 |